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ABSTRACT
Motivation: The proliferation of public data repositories creates a
need for meta-analysis methods to efficiently evaluate, integrate
and validate related datasets produced by independent groups.
A t-based approach has been proposed to integrate effect size
from multiple studies by modeling both intra- and between-study
variation. Recently, a non-parametric ‘rank product’ method, which
is derived based on biological reasoning of fold-change criteria, has
been applied to directly combine multiple datasets into one meta
study. Fisher’s Inverse 2 method, which only depends on P-values
from individual analyses of each dataset, has been used in a couple
of medical studies. While these methods address the question from
different angles, it is not clear how they compare with each other.
Results: We comparatively evaluate the three methods; t-based
hierarchical modeling, rank products and Fisher’s Inverse 2 test
with P-values from either the t-based or the rank product method.
A simulation study shows that the rank product method, in general,
has higher sensitivity and selectivity than the t-based method in
both individual and meta-analysis, especially in the setting of
small sample size and/or large between-study variation. Not
surprisingly, Fisher’s 2 method highly depends on the method
used in the individual analysis. Application to real datasets
demonstrates that meta-analysis achieves more reliable identifica-
tion than an individual analysis, and rank products are more robust in
gene ranking, which leads to a much higher reproducibility among
independent studies. Though t-based meta-analysis greatly
improves over the individual analysis, it suffers from a potentially
large amount of false positives when P-values serve as threshold.
We conclude that careful meta-analysis is a powerful tool for
integrating multiple array studies.
Contact: fxhong@jimmy.harvard.edu
Supplementary information: Supplementary data are available at
Bioinformatics online.
1 INTRODUCTION
High-throughput microarray technology has become a popular
tool for large-scale comparative analysis of gene expression
profiles. As a result, there are rapidly growing collections of
publicly available datasets that can be used for subsequent
analysis (Moreau et al., 2003). However, direct comparison
among heterogeneous datasets is not possible due to the
complicated experimental variables embedded in array experi-
ments (Irizarry et al., 2005; Kuo et al., 2002). Meta-analysis,
which consists of a set of statistical techniques to combine
results from several studies, appears to be a good and practical
solution. Recently, its applicability to microarray data was
demonstrated by different groups. Rhodes et al. (2002) applied
meta-analysis to combine four datasets on prostate cancer to
determine genes that are differentially expressed between
clinically localized prostate and benign tissue. Parmigiani
et al. (2004) performed a cross-study comparison of gene
expression for the molecular classification of lung cancer. Park
and Stegall (2007) combined publicly available and their own
microarray datasets to investigate the detection of cytokine
gene expression in human kidney. Meta-analysis has been
shown to have increased statistical power to detect small but
consistent effects that might be false negatives in the individual
analyses (Choi et al., 2003). It also has significantly improved
reproducibility when compared with independent studies,
which may lead to improved reliability (Hong et al., 2006).
Therefore, meta-analysis provides researchers with an indis-
pensable tool to interrogate existing databases for candidate
biomarkers and biological pathways.
Meta-analysis may be broadly defined as the quantitative
review and synthesis of the results of related but independent
studies (Normand, 1999). The objectives include increasing
power to detect an overall treatment effect and assessment of
the amount of variability between studies. The former is the
common task of most microarray experiments, which aim at
detecting differentially expressed genes among multiple condi-
tions (control versus treatment). Since the early days, many
simple and sophisticated statistical methods have been pro-
posed for this purpose in the individual experiments (Breitling
et al., 2004; Efron et al., 2001; Newton et al., 2004; Tusher
et al., 2001), and their performance has been thoroughly
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compared (Pan, 2002). However, complicated experimental
variables and different platforms used in microarray experi-
ments lead to more statistical issues than encountered in
standard meta-analysis, thus most standard methods can not be
applied directly for combining array datasets.
In recent years, several meta-analysis methods have been
proposed using different approaches. The most straightforward
one is Fisher’s Inverse 2 test (Fisher, 1925), which computes a
combined statistic from the P-values obtained from the analysis
of the individual datasets, S ¼ 2log(i Pi), where S follows a
2 distribution with 2I degrees of freedom under the joint null
hypothesis. This method is easy to use and does not require
additional analysis. However, by working with the P-values, it
is impossible to estimate the average magnitude of differential
expression.
Choi et al. (2003) adopted the classic biostatistical meta-
analysis framework (Normand, 1999) in array analysis and
used a t-like statistic (defined as effect size) as the summary
statistic for each gene from each individual dataset. They then
proposed a hierarchical modeling approach to assess both
intra- and inter-study variation in the summary statistic across
multiple datasets. This model-based method estimates an
overall effect size as the measurement of the magnitude of
differential expression for each gene through parameter
estimation and model fitting. The approach has been imple-
mented into a Bioconductor (Gentleman et al., 2004) package
GeneMeta that facilitates its application.
Recently, the non-parametric rank product (RP) method
has been introduced in another Bioconductor package
(RankProd) (Hong et al., 2006) to identify differentially
expressed genes, which has direct applicability in meta-analysis.
It is based on the rank product method of detecting
differentially expressed genes (Breitling et al., 2004) and offers
several advantages over linear models or t-tests, including a
biologically intuitive fold-change (FC) criterion, fewer assump-
tions and better robustness, which leads to increased power
in low sample number and/or large noise settings (Breitling
and Herzyk, 2005). Both the t-based and the RP method
utilize permutation tests to assess the statistical significance,
reporting the false discovery rate (FDR) of the identification
based on combined statistics. And both of them generate
P-values which can also serve as input for Fisher’s Inverse
Chi- square test.
In this article, we comparatively evaluate the three methods;
t-based hierarchical modeling using GeneMeta, the rank
product method with RankProd and Fisher’s Inverse 2 test
with P-values from the individual analysis of a single dataset
with each of the first two methods. ROC curves and pAUC
(Pepe, 2000) are utilized in a simulation study to quantify the
sensitivity and specificity of each method. We also apply the
methods to two sets of experimental microarray studies,
one with relatively small and one with relatively large
between-study variation. And we address the performance
based on two main criteria: (1) reproducibility measured by a
CAT plot (Irizarry et al., 2005) and (2) identification power
measured by integration-driven discovery rate (Choi et al.,
2003). We also briefly discuss other available meta-analysis
methods, such as Bayesian approaches (Wang et al., 2004),
linear models (Ghosh et al., 2003) and rank aggregation
(DeConde et al., 2006).
2 METHODS
Let T and C stand for two experimental conditions (treatment versus
control), and let there be i ¼ 1, . . . , I independent studies (datasets) and
(niT, niC) replicates for the ith study. Thus, for a given gene, the data is
recorded as Tij/Cij which is the (logged) gene expression level in the jth
replicate in treatment/control of the ith study. In the following sections,
we briefly describe the three methods.
2.1 The t-based modeling approach
The t-test and its variations are the most widely used approaches in
array analysis to identify differentially expressed genes. Meta-analysis
based on the t-statistic was reviewed by Normand (1999) in the context
of biostatistical applications, and it was adopted for microarray
analysis recently (Choi et al., 2003). Briefly, a standardized mean
difference was obtained as an effect size index for the measurement of





Ti and Ci represent the means of treatment and control group in the ith
study, and Sp indicates the estimated variation. Then we model the
effect size index di across studies by a hierarchical model:
di ¼ i þ "i; "i  Nð0; s2i Þ ð2Þ
i ¼ þ i; i  Nð0; 2Þ
where  denotes the parameter of interest (treatment effect), and 2 and
s2i represent the between-study and within-study variation. The model
has two different forms: a fixed-effect model (FEM) and a random
effect model (REM), depending on whether between-study variation is
ignorable. Choi et al. (2003) suggest to use Cochran’s Q statistic
(Cochran, 1954) to test homogeneity of study effect, which is assessing
the hypothesis that 2 is zero. Failure to reject the null hypothesis
should indicate the appropriateness of the FEM. Otherwise REM will
be used instead, where the estimator by DerSimonian and Laird (1986)
is used to estimate 2. Then this estimate is submitted to estimate  and
its variance Var[] by a point estimator
^ð2Þ ¼
Pðs2i þ 2Þ1diPðs2i þ 2Þ1
;Var½^ð2Þ ¼ 1Pðs2i þ 2Þ1
A Z-score will be derived from ^ð2Þ and Var½^ð2Þ to assess the
standardized average treatment effect for each gene across studies, zg,
g ¼ 1, . . . ,G.
To assess the statistical significance of the combined results, one
would obtain P-values from a standard normal distribution N(0,1)
using these Z-scores. However, it is preferred in array analysis that
permutation is used instead, to account for small sample size and to
avoid the violation of the normality assumption. In this case, column-
wise permutation is performed within each study to create randomized
data and z-scores under the null distribution, zg
b for permutation
b ¼ 1, 2, . . . , B. The ordered statistics z(g) (z(1)  . . .  z(p)) and zbðgÞ





ðgÞ IðjzbðgÞj  zgÞP
ðgÞ IðjzðgÞj  zgÞ
where I() is the indicator function. In the package GeneMeta, the FDR
estimation is carried out for up-regulation, down-regulation and
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two-side comparison, respectively. Based on similar reasoning, we can







where G is the total number of genes under study.
2.2 The rank product approach
The rank product is a non-parametric statistic that was first proposed
to detect differentially expressed genes in a single dataset (Breitling
et al., 2004). It is derived from biological reasoning about the fold-
change (FC) criterion and detects genes that are consistently found
among the most strongly up-regulated (or down-regulated) genes in a
number of replicate experiments. Moreover, the method offers a natural
way to overcome the heterogeneity among multiple datasets and
therefore can be extended to meta-analysis, which generates a single
significance measurement for each gene in the combined study (Hong
et al., 2006).
Here we describe the rank product meta-analysis algorithm using
two datasets as an example with (n1T, n1C) and (n2T, n2C) replicates,
respectively.
(1) For a one-channel array, compute pair-wise ratios or fold-
changes within each dataset; T1j/C1l, j ¼ 1, . . . , n1T, l ¼ 1, . . . ,n1C
) K1 ¼ n1T  n1C comparisons and T2j/C2l, j ¼ 1, . . . , n2T,
l¼1, . . . , n2C ) K2 ¼ n2T  n2C comparisons. (For two-channel
arrays, T1j/C1j, j ¼ 1, . . . , n1 and T2j/C2j, j ¼ 1, . . . , n1 with niT ¼
niC ¼ ni, so K1 ¼ n1 and K2 ¼ n2.)
(2) Rank fold-change (FC) within each comparison (largest FC )
rank 1) rgik: rank of gene g in ith study under kth comparison,
k ¼ 1, . . . , Ki.
(3) Combine K1 ranks from dataset 1 and K2 ranks from dataset 2,






where K ¼ K1 þ K2.
(4) Independently permute expression values within each single array
relative to gene ID, repeat step (1)–(3) and obtain the null rank
product statistic RPðbÞg .
(5) Repeat step (4) B times and form a reference distribution with
RPðbÞg , determine P-value and FDR associated with any given











ðgÞ IðjRPbðgÞj  RPgÞP
ðgÞ IðjRPðgÞj  RPgÞ
One-channel experiments, for the purpose of this discussion, include
Affymetrix gene-chips and two-color cDNA arrays with reference
design; direct two-color cDNA arrays are usually two-channel
experiments. The permutations are done by permuting the expression
value (ratio for two-channel experiments) within each array, rather than
by permuting the samples across arrays as in the t-based approach.
Basically, the algorithm computes pairwise FC with replicates for each
gene between treatment and control in both directions, respectively, and
transforms FC into rank among all genes under study, then searches for
genes that are consistently top ranked across replicates. Converting FC
into ranks increases robustness against noise and heterogeneity across
studies. Indeed, a recent study (Yuen et al., 2002 ) found that, although
the fold-changes of differentially expressed genes had poor consistency
across array platforms, the rank orders were comparable. This method
is also implemented in a Bioconductor package (RankProd).
2.3 Fisher’s inverse Chi-square approach
Moreau et al. (2003) reviewed several simple methods (called omnibus
procedures; Hedges and Olkin, 1985) that are available to test the
statistical significance of combined results based on P-values from each
single study. One method (Tippet, 1931) is to take the minimum P-value
(pmin) for each gene observed over different datasets but test this
minimum P-value at a higher stringency than the single study rejection
threshold : reject ‘no differential expression’ if pmin5 1-(1  )(1/I).
This method is sensitive to outliers, so a variant uses the nth smallest
P-value as an alternative (Wilkinson, 1951).
Another method is Fisher’s Inverse 2 test. It computes a combined
statistic from the P-values obtained from the individual datasets,
S ¼ 2logðipiÞ
which follows a 2 distribution with 2I degrees of freedom under the
joint null hypothesis and thus P-values of the combined statistic can be
calculated. Some researchers also extended Fisher’s method by giving
different weights to P-values from each dataset (Good, 1955). Weight
assignment can depend on the reliability of each P-value as a result of
data quality or on other factors considered important. To address the
issues of losing power due to a single very poor entry, Zaykin et al.
(2002) proposed a truncated product method (TPM) to calculate
Fisher’s product using a thresholding criterion where only P-values less
than or equal to some pre-specified cutoff value  contribute to the
combined product,
Sz ¼ 2logðiPiIðPiÞÞ
In addition to reducing false negatives, TPM also guards against false
positives by requiring the presence of at least one significantly small
P-value, which is rooted in the concern that a combination of
marginally significant P-values might suggest unreasonably high
significance of the combined statistic (Rosenthal, 1991). Pyne et al.
(2006) proposed a conservative way of controlling the combined FDR
at a specified level  by thresholding each experiment at FDR level 0
(0  2/4I2) with experiment-specific P-value cutoffs i, 0 following the
procedures by Benjamini and Hochberg (1995) or Storey (2002). One
aspect we need to point out is that Fisher’s product should be applied to
P-values for up-regulation and down-regulation separately, as random
opposite expression differences in a small sample setting would result in
marginally small P-values that lead to a high significance of the
combined statistic.
It is easy to notice that both the t-based and the rank product
approach can be applied to an individual dataset and P-values from
such individual analyses from either of them can be used in Fisher’s
product method. In this study, we will apply Fisher’s product using
P-values obtained from regular individual analyses with either t-based
or rank product approach, respectively. Since it is hard to threshold
with only two P-values available in our examples (Section 3), we will
use the original form of Fisher’s product as the test statistic and derive
P-values for the combined results from the null distribution. The
outcome will then be compared to that from meta-analysis with a
t-based or rank product approach.
2.4 Evaluation
We evaluate the performance of the above three methods by comparing
their power of detecting differential expression (sensitivity) and
reliability (specificity). We adopted receiver operating characteristic
(ROC) curves and associated partial area under the curve (pAUC)
(Pepe, 2000) in the simulated dataset, and Correspondence At the
Top (CAT) plots (Irizarry et al., 2005) in the real-data applications,
F.Hong and R.Breitling
376
for which the true differentially expressed genes are unknown. The
ROC curve is primarily a descriptive device displaying the range of
trade-offs between false positive rates and false negative rates for a
given test. The closer to the upper left-hand corner of the ROC space,
the better the performance of the given test. pAUC is the area under the
ROC curve in a restricted range of false-positive rates, often used as
summary index of test accuracy within a practical region of false
positive rates.
CAT plots are a reliability assessment tool introduced by Irizarry
et al. (2005), which assesses the agreement of the identification among
studies. Genes identified in multiple independent studies are likely to be
the truly significant ones, thus high reproducibility among independent
studies suggests a high specificity. It has been shown that correlation or
scatter plots of log2-fold changes are poor measurements of the
agreement among studies, as they are heavily influenced by large
amounts of non-differentially expressed genes. In practice, we are only
interested in a small subset of genes that appear to be differentially
expressed. Therefore, it is more important to assess agreement for genes
that are likely to be called significant (Irizarry et al., 2005). The
procedure for creating a CAT plot is to make a list of n top candidate
genes for each of the two studies, which can be individual or meta
studies, and plot the proportion in common against the list size n.
In other words, one plots the proportion of the top n genes identified in
one study that are ‘re-discovered’ in the top n genes of another study,
hence the alternative designation as ‘plot of rediscovery rate’. We have
three independent datasets in our application below, thus we will
perform meta-analysis with two of them and compare the results with
that from the third dataset (reference study) to draw CAT plots. In
addition, the proportion in common will be calculated among any two
of three individual analyses. The average proportion will be included in
the plot as the performance of the regular individual analysis.
We will use the integration-driven discovery (IDD) to measure the
extra power offered by integrating multiple datasets (Choi et al., 2003).
IDD was originally defined using cutoffs in Z-score and we modified it
to P-values in order to accommodate the outcomes from all three
methods. As we will generate P-values for both up-regulation and
down-regulation for each gene, we use (pupi , p
dn
i ) and (p
up, pdn) to denote
the significance in each comparison for the individual study i and
combined meta-analysis. The IDD is defined as
ðpup  pthÞ and ðpupi 4pth for i ¼ 1; . . . ; IÞ
or
ðpdn  pthÞ and ðpdni 4pth for i ¼ 1; . . . ; IÞ
IDD is the number of extra genes identified by meta-analysis compared
with the union set of all individual studies at the same p-threshold level
(pth). Integration-driven discovery rate (IDR), defined as the ratio of
IDD to the total number of discoveries, will be listed for a series of
small P-value thresholds for each method. However, a low IDR, which
suggests a subtly increased power, might be due to a relatively high
power of the given method in the individual studies, which indeed
indicates better performance. Moreover, a high IDD might lead to a
potentially decreased specificity, as more false positives might appear
with more genes identified, particularly as the p-threshold increases.
Therefore, we consider the measurement of ‘reproducibility’ or
reliability by CAT plot a better evaluation criterion.
3 RESULTS
3.1 Simulation
To evaluate the performance of the three meta-analysis
methods, we first simulated expression levels of G¼ 5000
genes under two conditions T(treatment) and C(control) from 3
(I ¼ 3) independent studies based on a t-based model as
Cgik ¼ g þ gi þ "gik; ð3Þ
Tgik0 ¼ g þ gi þ gi þ "gik0
and
gi ¼ g þ ig
where Cgik and Tgik0 are logged expression levels of gene g in the
ith study under control (k ¼ 1, . . . , K1 replicate) and treatment
(k0 ¼ 1, . . . , K2 replicate). For simplicity, we let K1 ¼ K2 ¼ K.
g is the mean expression under control, and gi represents its
variation among studies. gi stands for the expression difference
in the ith study, which contains a true difference g and its
variation ig among studies. We notice that gi can be ignored
as it will be canceled in both t-based and rank product analysis.
In order to mimic experimental microarray studies, we gen-
erated data (Cgik, Tgik) based on rough parameter estimates
using a point estimator from the experimental data used in the
following sections. For example, since the mean logged
expression for all genes ranged from 3–13 in the hormone
data (Section 3), we simulated g from Unif(3,14); we randomly
selected 10% true differentially expressed genes with g 
Unif(3, 3). We allow ig to have gene-specific between-study
variation, ig  Nð0; 2gÞ, and use an inverse gamma distribution
to generate 2g  IGða; bÞ. We also simulated within-study error
"gik, "gik0 from normal distributions with different error
variation in three independent studies as Nð0; s2i Þ, s2i ¼ 0:03;
0.05, 0.08. To explore the effect of between-study variation (2g)
and sample size (K), we simulated 6 scenarios listed in the Table
1, with (1) relatively large variation (LV) a ¼ 3, b ¼ 0.2,
Eð2gÞ ¼ 0:2, Varð2gÞ ¼ 0:04 and (2) relatively small variation
(SV) a ¼ 3, b ¼ 0.02, Eð2gÞ ¼ 0:02, Varð2gÞ ¼ 0:0004 and three
settings of sample size, K¼3, 5,10, which covers the range where
meta-analysis is likely to be most beneficial.
For each scenario, we applied the rank product and t-based
method to each of the three datasets and calculated average
results as the performance of the individual analysis.
We then selected two datasets at a time [C(3, 2) ¼ 3 times]
for meta-analysis and also got average outcomes from
three meta-analyses. By comparing the identifications with
the true differentially expressed genes, we plotted the ROC
Table 1. pAUC from the false positive range 0–0.05 for all six senarios
presented in simulation studies. ‘F-meta’ stands for meta-analysis using
Fisher’s product with P-values from either of the two methods
2g  IGða; bÞ a¼ 3, b¼ 0.4 (LV) a¼ 3, b¼ 0.04 (SV)
Sample Size K¼ 3 K¼ 5 K¼ 10 K¼ 3 K¼ 5 K¼ 10
Single RP 0.028 0.027 0.027 0.032 0.040 0.039
t-based 0.019 0.021 0.027 0.032 0.032 0.038
Meta RP 0.034 0.033 0.033 0.039 0.039 0.038
t-based 0.027 0.026 0.034 0.039 0.040 0.037
F-meta RP 0.034 0.033 0.033 0.039 0.039 0.038
t-based 0.033 0.022 0.005 0.039 0.038 0.034
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curves for the top n ¼ 50, 100, . . . , 1000 identified genes
(Supplementary Fig. 1) and for a series of selected P-value
thresholds 0.0001. . .0.01 (Supplementary Fig. 2) in all six
scenarios. Figure 1 shows an example (K¼ 3, LV). pAUC
values within the standard false positive rate region (0–0.05) are
summarized for all six scenarios in Table 1.
The series of ROC plots and pAUC summaries in Table 1
highlights several findings. First, as expected, meta-analysis
with either method achieves better outcomes compared to
single analysis, suggesting increased power and specificity.
However, the improvement becomes less predominant as g
(between-study variation) decreases and K (sample size)
increases. Second, rank products outperform the t-based
method with a better tradeoff between sensitivity and specificity,
especially in single analysis and in the low false positive
rate region. Again, the advantage gets smaller when K increases
and/or  decreases. Third, the t-based method generates inflated
P-values (Supplementary Fig. 3) leading to high false-positive
rates even at small P-value thresholds, as indicated by the shift
of the ROC curve to the right. P-values from rank products
appear to be a more reliable measurement of significance.
Finally, the performance of Fisher’s method highly depends on
the quality of P-values from the simple individual analysis. The
inflation of P-values escalates when applying Fisher’s method
with P-values from the t-based method, which leads to an
unacceptably large number of false discoveries in Fisher’s
method.
3.2 Controlled human array data
This dataset was originally presented by Irizarry et al. (2005) as
the controlled experiment for a multiple-laboratory comparison
of three different microarray platforms: Affymetrix Genechips,
two-color spotted cDNA arrays, and two-color long oligonu-
cleotide arrays. Two RNA samples were created in which only
a few genes were expected to be differentially expressed. Two
technical copies were made for each of them, given to
researchers in 10 labs from the Washington, DC–Baltimore
area, and processed according to what was considered best
practice in each lab. We selected data from lab 1, 2 and 3 out of
5 labs which utilized Affymetrix gene-chips platform as the
testing datasets. We expect both intra-study and between-study
variations to be small due to the technically replicated RNA
sample and the same platform being utilized in all three labs.
Similar to the simulation study, we performed an individual
analysis for each of three datasets, and seleted two datasets at a
time [C(3, 2)¼3 times] for meta-analysis. The average outcomes
from three individual and three meta-analyses are used in the
comparison. A Q-test indicated that an FEM is appropriate in
the t-based method, which confirms that the inter-study
variation is ignorable. As we only expect very few differentially
expressed genes, we use several low P-values as the cutoff point
in Table 2 and list the number of genes identified in the
individual and meta-analysis as well as the integration-driven
discovery rate (in parenthesis). As shown in Table 2, meta-
analysis is able to identify more genes at the same p-level,
suggesting an increased power and a potentially low false
negative rate. However, unexpectedly large amounts of genes
are identified by t-based methods, particularly with Fisher’s
product, making it suspicious of potentially high false positive
rates as already indicated in the simulation study. We notice
that rank products identified a significant amount of genes
at low FDR level (50.05), while the model-based method
failed to identify any genes at the same FDR level. Due to
the small scale of between-study and within-study variation,
unsurprisingly, most of the genes identified in the individual
studies were confirmed or re-identified in meta-analysis.
Furthermore, we see higher significance (smaller P-values)
in meta-analysis for genes with consistent but small changes
(data not shown), suggesting an increased confidence regarding
the identification.
Treating the top n genes identified in the third dataset as the
reference, we compared the top n genes identified in dataset
1 and 2, as well as the top n genes from meta-analysis
combining dataset 1 and 2. The percentage in common among
the top genes is presented in CAT plots. Since we would only
expect a small number of differentially expressed genes, the
CAT plots (Fig. 2) are drawn for the top 400 genes (200
up-regulated and 200 down-regulated) identified from each
analysis. Meta-analysis, in general, gains higher reliability
compared to single analysis, suggesting that the result is more
likely to be reproduced by an independent study. However, the
rediscovery rate is much higher for rank products compared to
that of the t-based method for both individual and meta-
analysis. For example, the rediscovery rate is above 60% in all
analyses with rank products, while it is below 50% with the
t-based method. This is consistent with the simulation study,
Fig. 1. Partial ROC curves for simulated datasets (K¼3, LV) with rank
product (red) and t-based method (black) for the top 1000 identified
genes (top) and for a series of selected P-value thresholds
0.0001,. . .,0.01 (bottom). ‘-s-’: individual analysis; ‘-M-’: meta-analysis
with rank product/t-based approach; ‘-f-’: meta-analysis using Fisher’s
product with P-values from either of the two methods. Note the ‘-f-’
and ‘-M-’ in red are overlapped.
F.Hong and R.Breitling
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where rank products yield more robust gene ranking for the top
genes, leading to higher reproducibility and increased specifi-
city. This might be due to the robustness of rank products
against noise. Surprisingly, Fisher’s product appears to have
higher reproducibility than the t-based method, suggesting that
meta-analysis using a t-based model might add another level of
instability, which is prevented by Fisher’s approach.
3.3 Plant hormone data
Here we meta-analyzed three array experiments that have been
carried out in two laboratories (Shimada and Chory) to study
the effect of a particular hormone on plant growth. Each of the
three studies compares gene expression profiles at 3 h after
hormone treatment to non-treatment control plants (Vert et al.,
2005). Shimada’s group in Japan first conducted two very
similar experiments, each with two replicates; one with the
Affymetrix 8K GeneChip, representing 1/3 of the Arabidopsis
genome, and one with Affymetrix ATH1 arrays, representing
(approximately) the whole genome. Chory’s group in the USA
reported a third similar experiment using the Affymetrix
ATH1 array with three replicates for each condition
(Nemhauser et al., 2004). All three datasets were preprocessed
using gcRMA (Wu et al., 2004) in Bioconductor and 7000
common genes were extracted and used in the evaluation.
Quality checks (not shown) indicate severe heterogeneity
among the three datasets and a strong ‘lab effect’ as the two
datasets from Shimada’s group, although using different types
of GeneChip, are much more similar to each other than to the
data from Chory’s group. To reduce the disruption by lab effect
in computing the rediscovery rate, we used the two datasets
from Shimada’s group to practice meta-analysis and treat the
Chory data as the reference. A Q-test for heterogeneity found
that the REM was appropriate when the t-based method is used
for this dataset.
While reporting integration driven discoveries in Table 3, we
can also see that a larger percentage of discoveries in the simple
analyses are not identified by meta-analysis using the t-based
method compared to the rank product method. This indicates a
potentially high false positive rate and/or low robustness in gene
ranking of the t-based approach. For example, only 26% genes
were re-discovered in meta-analysis at p ¼ 0.01 level and even
worse for lower p-thresholds. Similarly to the controlled human
data, rank products identified more genes at the lower p-levels.
Together, this again suggests that rank products have higher
selectivity and sensitivity than the t-based method in case of
small sample size and large noise. Since, biologically, plant
hormones affect plant growth in a global way, we expect expres-
sion level changes for a large number of genes, so we chose to
expand the re-discovery rate comparison to the top 1000 up-
regulated and 1000 down-regulated genes. Similar to Figure 2,
figure 3 confirmed the increased re-discovery rate with meta-
analysis in both up- and down-regulated gene sets, and rank
products have much higher reproducibility than the t-based
method in this dataset, too. One should notice the extremely low
reproducibility of the t-based method in single analysis
(essentially just a t-test), indicating much higher false positive
rates, which is consistent with what we observed in the IDR table
(Table 3). Fisher’s product appears to have similar performance
(slightly worse) as rank products and the t-based method in this
dataset, when using P-values from each method, respectively.
4 DISCUSSION
4.1 A comparative summary of the three methods
It is clear that Fisher’s product uses only P-values from
each single dataset; its performance heavily depends on the
Fig. 2. CAT plot of the controlled data with rank product (left panel)
and t-based approach (right panel). ‘-s-’(red): individual analysis;
‘-M-’(black): meta-analysis with rank product/t-based approach; ‘-f-’
(blue): meta-analysis using Fisher’s product with P-values from each of
the two methods. The dotted horizontal line indicates 50% agreement.
Table 3. Plant hormone data set
P Rank Product t-based
Single Meta-RP Meta-F Single Meta-t Meta-F
0.001 136 260 (0.5) 247 (0.47) 37 94 (0.98) 74 (0.64)
0.005 292 447 (0.40) 417 (0.35) 159 295 (0.92) 220 (0.51)
0.01 424 566 (0.32) 550 (0.29) 317 491 (0.83) 368 (0.39)
0.05 1132 1039 (0.13) 999 (0.10) 1425 1352 (0.38) 1105 (0.11)
‘single’: Union set of genes identified from the individual analyses.
Table 2. Controlled data set: average number of genes identified at
different P-levels and integration-driven discovery rate (IDD) in meta-
analysis (shown in parenthesis) using rank product (Meta-RP) and
t-based approach (Meta-t). The results with Fisher’s product are listed
as ‘Meta-F’
P Rank Product t-based
Single Meta-RP Meta-F Single Meta-t Meta-F
1e-4 47 166 (0.72) 150 (0.69) 7 87 (0.98) 496 (0.99)
5e-4 100 233 (0.58) 221 (0.55) 39 229 (0.92) 721 (0.94)
1e-3 137 281 (0.52) 259 (0.48) 75 332 (0.84) 839 (0.89)
5e-3 280 449 (0.40) 424 (0.36) 280 672 (0.62) 1243 (0.73)
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underlying method used to calculate p. Therefore, we will focus
our discussion on the two methods used to generate the
P-values.
Both t-based and rank product approaches are derived or
extended from the ones used in simple analysis, therefore they
largely inherit their features in simple analysis. The t-based
approach originates from Student’s t-test and provides a
flexible selection of a fixed-effect or random-effect model
based on homogeneity tests and an overall measure of
differential expression for each gene. The latter feature offers
a direct comparison of the magnitude of a treatment on
different genes. Rank products, however, do not have this
feature but only provide the relative position of a gene
compared with all other genes under study for judging its
expression difference.
On the other hand, rank products have advantages over
t-based approaches in terms of robustness in ranking genes.
In most array studies with small sample size, t-based methods
suffer from unreliable error estimates, therefore gene ranking
substantially varies from experiment to experiment, which
causes a low specificity as shown in our simulation, or a low
reproducibility in experimental applications. Although increas-
ing sample size would improve the performance of the t-based
method as shown in simulation studies, it is uncommon to
have large sample size in laboratory biological experiments.
The poor reproducibility has been a major concern, discoura-
ging some biologists from trusting the results of array
experiments. It is indeed exciting news that combining multiple
studies significantly improves reliability (Figs 2 and 3).
Importantly, it appears that rank products have consistently
the highest reproducibility/specificity in both simulation
and experimental data applications, regardless of the scale
of heterogeneity among datasets. This observation suggests that
gene rankings from the rank product method are more robust
against noise and other hidden variables embedded in different
datasets.
4.2 Comparison to other meta-analysis approaches
Wang et al. (2004) introduced a meta-analysis method from
a Bayesian perspective. The basic idea is to treat one dataset
as prior knowledge that gives preliminary information about
the expression difference for the given gene and then to
increase our knowledge by adding another dataset to get an
updated posterior assessment of the expression change. Let
D1 ¼ T1  C1 and s21 be the estimate of expression change and
its estimated variance from the first dataset. If we assume a
normal distribution of the errors in measurement, a well-known
Bayesian calculation shows that the best estimate of the true












In other words, we combine difference measurements from
different datasets by weighting them using variance. It is easy
to show that this formula generalizes to the scenario of
multiple datasets and the final results does not depend on





ið1=s2i Þ and 1=s2combined ¼
P
ið1=s2i Þ.
However, a simple derivation can show that the above
method is indeed the maximum likelihood estimator (MLE)
for the t-based modeling approach introduced in Section 3
under the fixed-effects model, if we change the effect size di to
Yi ¼ Ti  Ci (Normand, 1999). We consider the standardized
(scale-free) statistic di more appropriate when datasets are
generated from different laboratories, therefore we do not treat
the Bayesian approach as a fundamentally different method.
Indeed, application to simulated data confirms that the
Bayesian approach has very similar outcomes to the t-based
method (data not shown).
Ghosh et al. (2003) proposed another two t-test based
approaches. The first one utilizes a weighted average of the





as the test statistics and obtains statistical significance from
permutation. The second algorithm has a more general formula
with study effect as main effect as well as interaction with each
gene. Let Yi¼(Ti1. . .TiniT, Ci1, . . . ,CiniC) denote the expression of
a given gene in the ith study with a total of k ¼ 1, . . . , (niT þ niC)
samples, the model is written as
E½Yik ¼ 0i þ 1iXk þ 2iZi þ 3iXkZi ð5Þ
where Xk is a covariate for experimental condition (treatment
versus control) of the kth sample and Zi is the study indicator.
A likelihood test for testing H0 : 1i¼3i¼0 would yield a set of
test statistics (based on least square estimates) for assessing
differential expression, and a permutation test is proposed to
generate significance measurements. One should notice that
model 4 assumes the treatment effect is the same across all
Fig. 3. CAT plot of the plant hormone data with rank product (left)
and model-based approach (right). ‘-1-’(red) and ‘-2-’(green) shows
overlap between dataset 1, 2, and the reference. ‘-M-’(black): meta-
analysis with rank product/t-based approach; ‘-f-’(blue): meta-analysis
using Fisher’s product with P-values from each of the two methods.
The dotted horizontal line indicates the position of 50% agreement.
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the studies, which is similar to the FEM in model 3, while
model 5 assumes treatment effect varies between studies, which
is the idea of the REM in model 3. As a result, these approaches
are so similar to the t-based method that they share most of its
features illustrated above.
The various rank aggregation approaches of DeConde et al.
(2006) are based on meta-search methods from computer
science, which are used to combine lists of search results.
Because the concept works on rank-ordered lists, it will share
many of the advantageous performance characteristics of
rank products. On test data from five different prostate
cancer datasets (DeConde et al., 2006), the performance
of rank aggregation and rank products is indistinguishable
(not shown). Therefore, rank aggregation can be considered an
interesting alternative to rank products and should be further
investigated.
5 CONCLUSION
In this article, we compare the performance of three meta-
analysis methods for microarray studies, using array data
generated on the Affymetrix platform. At the data analysis
level, we limited our comparison to the improvement of the
detection of differential expression, as this is currently the most
common aim of microarray experiments. The heterogeneity
among multiple datasets leads to many statistical issues
affecting the integration process. Our study shows that meta-
analysis achieves increased power and higher reproducibility by
integrating multiple datasets. In general, the non-parametric
rank product method outperforms the other methods in terms
of sensitivity and specificity, especially in a setting of small
sample size and large between-study variation. This suggests
that rank products should be preferred in such a setting since
transferring fold-changes into ranks increases the robustness
against variations from different sources. In addition, simula-
tion shows that P-values from the rank product approach are a
more reliable significance measurement than those from the
t-based method. Nevertheless, the t-based method can achieve
dramatic improvements in terms of gene ranking when
combining multiple studies together.
Fisher’s 2 method appears to be highly dependent on the
methods used in the individual analysis. It yields rather poor
results in combination with t-based methods, and performs
similar to rank product-based meta-analysis. Therefore, we do
not suggest usage of Fisher’s method in combining multiple
dataset unless only P-values are available. Our work also points
out that there will be a substantial amount of false positives in
the list of genes identified in the individual studies with low
sample size and large scale of heterogeneity when a t-based
method is used, which contributes to the poor consistency
among independent studies as reported before by different
research groups (Jarvinen et al., 2004; Kothapalli et al., 2002).
The availability of public array repositories opens up a new
realm of possibilities for microarray data analysis. An essential
challenge is the efficient integration of array data generated by
different laboratories and/or different platforms. Currently,
there are several ( 4) popular array technologies. It is still
unclear how measurements from different platforms compare
with each other (Moreau et al., 2003), and inconsistencies in
gene coverage and annotation make comparisons very difficult.
It will be an interesting topic to further explore meta-analysis
across different platforms, which is not the scope of this study.
As large amounts of data are being produced on a daily basis
using a wide variety of experimental designs and technologies,
meta-analysis could be beneficial in a much wider range of
applications, such as integrating time-course genomic data and
proteomic experiments (Varambally et al., 2005). Therefore, we
are expecting additional developments of methods for meta-
analysis which will significantly enhance our ability to benefit
from these powerful high-throughput technologies.
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